Abstract
This Practice Point commentary discusses the findings of a study by Maruyama et al., in which treatment with insulin was compared to sulfonylurea in 60 patients with slowly progressive insulin-dependent diabetes mellitus (SPIDDM), a presumed form of latent autoimmune diabetes in adults (LADA). Patients who received insulin had a lower rate of progression to insulin dependency than patients who received sulfonylurea (10% versus 43%, P = 0.003). Here, I review the history of LADA and the current approach to diagnosis and treatment. Diagnosis of LADA is generally by the detection of glutamic acid decarboxylase antibodies in adults who present with the clinical features of type 2 diabetes mellitus, providing presumptive evidence of autoimmunity. Treatment of LADA is usually with insulin, an approach supported by the findings of the study. Nonetheless, some evidence suggests that sulfonylurea actually accelerates loss of β-cell function. Whether this effect had a role in the results obtained by the Maruyama et al. is not yet clear.
| Original language | English |
|---|---|
| Pages (from-to) | 600-601 |
| Number of pages | 2 |
| Journal | Nature Clinical Practice Endocrinology and Metabolism |
| Volume | 4 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 1 2008 |
Fingerprint
Keywords
- Insulin
- Latent autoimmune diabetes in adults
- Slowly progressive insulin-dependent diabetes mellitus
- Sulfonylurea
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Endocrinology
Cite this
Latent autoimmune diabetes in adults : The search for interventions continues. / Skyler, Jay S.
In: Nature Clinical Practice Endocrinology and Metabolism, Vol. 4, No. 11, 01.11.2008, p. 600-601.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Latent autoimmune diabetes in adults
T2 - The search for interventions continues
AU - Skyler, Jay S
PY - 2008/11/1
Y1 - 2008/11/1
N2 - This Practice Point commentary discusses the findings of a study by Maruyama et al., in which treatment with insulin was compared to sulfonylurea in 60 patients with slowly progressive insulin-dependent diabetes mellitus (SPIDDM), a presumed form of latent autoimmune diabetes in adults (LADA). Patients who received insulin had a lower rate of progression to insulin dependency than patients who received sulfonylurea (10% versus 43%, P = 0.003). Here, I review the history of LADA and the current approach to diagnosis and treatment. Diagnosis of LADA is generally by the detection of glutamic acid decarboxylase antibodies in adults who present with the clinical features of type 2 diabetes mellitus, providing presumptive evidence of autoimmunity. Treatment of LADA is usually with insulin, an approach supported by the findings of the study. Nonetheless, some evidence suggests that sulfonylurea actually accelerates loss of β-cell function. Whether this effect had a role in the results obtained by the Maruyama et al. is not yet clear.
AB - This Practice Point commentary discusses the findings of a study by Maruyama et al., in which treatment with insulin was compared to sulfonylurea in 60 patients with slowly progressive insulin-dependent diabetes mellitus (SPIDDM), a presumed form of latent autoimmune diabetes in adults (LADA). Patients who received insulin had a lower rate of progression to insulin dependency than patients who received sulfonylurea (10% versus 43%, P = 0.003). Here, I review the history of LADA and the current approach to diagnosis and treatment. Diagnosis of LADA is generally by the detection of glutamic acid decarboxylase antibodies in adults who present with the clinical features of type 2 diabetes mellitus, providing presumptive evidence of autoimmunity. Treatment of LADA is usually with insulin, an approach supported by the findings of the study. Nonetheless, some evidence suggests that sulfonylurea actually accelerates loss of β-cell function. Whether this effect had a role in the results obtained by the Maruyama et al. is not yet clear.
KW - Insulin
KW - Latent autoimmune diabetes in adults
KW - Slowly progressive insulin-dependent diabetes mellitus
KW - Sulfonylurea
UR - http://www.scopus.com/inward/record.url?scp=54549124435&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=54549124435&partnerID=8YFLogxK
U2 - 10.1038/ncpendmet0949
DO - 10.1038/ncpendmet0949
M3 - Article
C2 - 18762790
AN - SCOPUS:54549124435
VL - 4
SP - 600
EP - 601
JO - Nature Reviews Endocrinology
JF - Nature Reviews Endocrinology
SN - 1759-5029
IS - 11
ER -